[1] WANG Y, XIAO Y, ZHONG L, et al. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with beta-cell autoimmunity in patients with type 1 diabetes [J]. Diabetes, 2014, 63(12): 4239-4248.
[2] SCHRIJVER G, SCHALKWIJK J, ROBBEN J C, et al. Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase [J]. J Exp Med, 1989, 169(4): 1435-1448.
[3] FUJIMURA N, OBARA H, SUDA K, et al. Neutrophil elastase inhibitor improves survival rate after ischemia reperfusion injury caused by supravisceral aortic clamping in rats [J]. J Surg Res, 2013, 180(1): e31-e36.
[4] SAKAI S, TAJIMA H, MIYASHITA T, et al. Sivelestat sodium hydrate inhibits neutrophil migration to the vessel wall and suppresses hepatic ischemia-reperfusion injury [J]. Dig Dis Sci, 2014, 59(4): 787-794.
[5] MULEY M M, REID A R, BOTZ B, et al. Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2 [J]. Br J Pharmacol, 2016, 173(4): 766-777.
[6] DI M L, MICHELI L, CINCI L, et al. Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis [J]. Rheumatology (Oxford, England), 2016, 55(7): 1285-1294.
[7] TSUJII S, OKABAYASHI T, SHIGA M, et al. The effect of the neutrophil elastase inhibitor sivelestat on early injury after liver resection [J]. World J Surg, 2012, 36(5): 1122-1127.
[8] HASMANN A, GEWESSLER U, HULLA E, et al. Sensor materials for the detection of human neutrophil elastase and cathepsin G activity in wound fluid [J]. Exp Dermatol, 2011, 20(6): 508-513.
[9] MITTENDORF E A, ALATRASH G, QIAO N, et al. Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response [J]. Cancer Res, 2012, 72(13): 3153-3162.
[10] GREGORY A D, HALE P, PERLMUTTER D H, et al. Clathrin pit-mediated endocytosis of neutrophil elastase and cathepsin G by cancer cells [J]. J Biol Chem, 2012, 287(42): 35341-35350.
[11] GROSSE-STEFFEN T, GIESE T, GIESE N, et al. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase [J]. Clin Dev Immunol, 2012, 2012: 720-768.
[12] NAWA M, OSADA S, MORIMITSU K, et al. Growth effect of neutrophil elastase on breast cancer: favorable action of sivelestat and application to anti-HER2 therapy [J]. Anticancer Res, 2012, 32(1): 13-19.
[13] HO A S, CHEN C H, CHENG C C, et al. Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers [J]. Oncotarget, 2014, 5(2): 473-480.
[14] SUN Z, YANG P. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression [J]. Lancet Oncol, 2004, 5(3): 182-190.
[15] FENG L, LI Y M. Research progress in natural inhibitors of neutrophil elastase and their screening method [J]. Chin Tradit Pat Med(中成药), 2012, 34(5): 914-918.
[16] WANG R, GAO X D. Studies on human neutrophil elastase and its inhibitors [J]. Prog Pharm Sci(药学进展), 2005, 29(8): 350-354.
[17] RICE W G, WEISS S J. Regulation of proteolysis at the neutrophil substrate interface by secretory leukoprotease inhibitor [J]. Science, 1990, 249(4965): 178-181.
[18] MIYOSHI S, HAMADA H, ITO R, et al. Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis [J]. Drug Des Dev Ther, 2013, 7(1):305-316.
[19] HAYASHIDA K, FUJISHIMA S, SASAO K, et al. Early administration of sivelestat, the neutrophil elastase inhibitor, in adults for acute lung injury following gastric aspiration [J]. Shock (Augusta, Ga), 2011, 36(3): 223-227.
[20] AIKAWA N, ISHIZAKA A, HIRASAWA H, et al. Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor, sivelestat, for the treatment of acute lung injury associated with systemic inflammatory response syndrome; a phase Ⅳ study [J]. Pulm Pharmacol Ther, 2011, 24(5): 549-554.
[21] KOHIRA S, OKA N, INOUE N, et al. Effect of additional preoperative administration of the neutrophil elastase inhibitor sivelestat on perioperative inflammatory response after pediatric heart surgery with cardiopulmonary bypass [J]. Artif Organs, 2014, 38(12): 1018-1023.
[22] NISHIYAMA J, MATSUDA M, ANDO S, et al. The effects of the early administration of sivelestat sodium, a selective neutrophil elastase inhibitor, on the postoperative course after radical surgery for esophageal cancer [J]. Surg Today, 2012, 42(7): 659-665.
[23] OHBAYASHI H. Neutrophil elastase inhibitors as treatment for COPD [J]. Expert Opin Investig Drugs, 2002, 11(7): 965-980.
[24] HUANG W, YAMAMOTO Y, LI Y, et al. X-ray snapshot of the mechanism of inactivation of human neutrophil elastase by 1, 2, 5-thiadiazolidin-3-one 1, 1-dioxide derivatives [J]. J Med Chem, 2008, 51(7): 2003-2008.
[25] STEVENS T, EKHOLM K, GRANSE M, et al. AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase [J]. J Pharmacol Exp Ther, 2011, 339(1): 313-320.
[26] GUNAWARDENA K A, GULLSTRAND H, PERRETT J. Pharmacokinetics and safety of AZD9668, an oral neutrophil elastase inhibitor, in healthy volunteers and patients with COPD [J]. Int J Clin Pharmacol Ther, 2013, 51(4): 288-304.
[27] STOCKLEY R, DE SOYZA A, GUNAWARDENA K, et al. Phase Ⅱ study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis [J]. Respir Med, 2013, 107(4): 524-533.
[28] VOGELMEIER C, AQUINO T O, O′BRIEN C D, et al. A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium [J]. J Chronic Dis, 2012, 9(2): 111-120.
[29] KUNA P, JENKINS M, O′BRIEN C D, et al. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD [J]. Respir Med, 2012, 106(4): 531-539.
[30] GIOVANNONI M P, SCHEPETKIN I A, CROCETTI L, et al. Cinnoline derivatives as human neutrophil elastase inhibitors [J]. J Enzyme Inhib Med Chem, 2016, 31(4): 628-639.
[31] CROCETTI L, GIOVANNONI M P, SCHEPETKIN I A, et al. Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase [J]. Bioorg Med Chem, 2011, 19(15): 4460-4472.
[32] CROCETTI L, SCHEPETKIN I A, CILIBRIZZI A, et al. Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase [J]. J Med Chem, 2013, 56(15): 6259-6272.
[33] LUCAS S D, GONCALVES L M, CARVALHO L A, et al. Optimization of O3-acyl kojic acid derivatives as potent and selective human neutrophil elastase inhibitors [J]. J Med Chem, 2013, 56(23): 9802-9806.
[34] MONTALBANO F, CAL P M, CARVALHO M A, et al. Discovery of new heterocycles with activity against human neutrophile elastase based on a boron promoted one-pot assembly reaction [J]. Org Biomol Chem, 2013, 11(27): 4465-4472.
[35] HANSEN G, GIELEN-HAERTWIG H, REINEMER P, et al. Unexpected active-site flexibility in the structure of human neutrophil elastase in complex with a new dihydropyrimidone inhibitor [J]. J Mol Biol, 2011, 409(5): 681-691.
[36] VON N F, LI V M, ALLERHEILIGEN S, et al. Freezing the bioactive conformation to boost potency: the identification of BAY 85-8501, a selective and potent inhibitor of human neutrophil elastase for pulmonary diseases [J]. Chem Med Chem, 2015, 10(7): 1163-1173.
[37] VON N F, LI V M, MEIBOM D, et al. Potent and selective human neutrophil elastase inhibitors with novel equatorial ring topology: in vivo efficacy of the polar pyrimidopyridazine BAY-8040 in a pulmonary arterial hypertension rat model [J]. Chem Med Chem, 2016, 11(2): 199-206.
[38] SIENCZYK M, PODGORSKI D, BLAZEJEWSKA A, et al. Phosphonic pseudopeptides as human neutrophil elastase inhibitors--a combinatorial approach [J]. Bioorg Med Chem, 2011, 19(3): 1277-1284.
[39] WINIARSKI L, OLEKSYSZYN J, SIENCZYK M. Human neutrophil elastase phosphonic inhibitors with improved potency of action [J]. J Med Chem, 2012, 55(14): 6541-6553.
[40] SIENCZYK M, WINIARSKI L, KASPERKIEWICZ P, et al. Simple phosphonic inhibitors of human neutrophil elastase [J]. Bioorg Med Chem Lett, 2011, 21(5): 1310-1314.
[41] MADSEN J L, ANDERSEN T L, SANTAMARIA S, et al. Synthesis and evaluation of silanediols as highly selective uncompetitive inhibitors of human neutrophil elastase [J]. J Med Chem, 2012, 55(17): 7900-7908.
[42] HUANG G, FENG L, LIU B, et al. Synthesis and biological evaluation of nigranoic acid esters as novel human neutrophil elastase inhibitors [J]. Nat Prod Res, 2015, 29(17): 1650-1656.
[43] KABEYA L M, FUZISSAKI C N, ANDRADE M F, et al. 4-Methylcoumarin derivatives inhibit human neutrophil oxidative metabolism and elastase activity [J]. J Med Food, 2013, 16(8): 692-700.
[44] HWANG T L, WANG W H, WANG T Y, et al. Synthesis and pharmacological characterization of 2-aminobenzaldehyde oxime analogs as dual inhibitors of neutrophil elastase and proteinase 3 [J]. Bioorg Med Chem, 2015, 23(5): 1123-1134.
[45] LEE I S, KIM K C, YOO I D, et al. Inhibition of human neutrophil elastase by labdane diterpenes from the fruiting bodies of Ramaria formosa[J]. Biosci Biotechnol Biochem, 2015, 79(12): 1921-1925.
[46] FENG L, LIU X, ZHU W, et al. Inhibition of human neutrophil elastase by pentacyclic triterpenes [J]. PLoS One, 2013, 8(12): e82794.
[47] KIM K C, LEE I S, YOO I D, et al. Sesquiterpenes from the fruiting bodies of Ramaria formosa and their human neutrophil elastase inhibitory activity [J]. Chem Pharm Bull, 2015, 63(7): 554-557.
[48] LEE I S, BAE K, KUK Y J, et al. Inhibition of human neutrophil elastase by ergosterol derivatives from the mycelium of Phellinus linteus[J]. J Antibiot, 2012, 65(8): 437-440.
[49] LEE I S, RYOO I J, KWON K Y, et al. Pleurone, a novel human neutrophil elastase inhibitor from the fruiting bodies of the mushroom Pleurotus eryngii Var. ferulae [J]. J Antibiot, 2011, 64(8): 587-589.
[50] HUANG Y, CHEN L, FENG L, et al. Characterization of total phenolic constituents from the stems of Spatholobus suberectus using LC-DAD-MS(n) and their inhibitory effect on human neutrophil elastase activity [J]. Molecules, 2013, 18(7): 7549-7556.
[51] TSAI Y F, YU H P, CHANG W Y, et al. Sirtinol inhibits neutrophil elastase activity and attenuates lipopolysaccharide-mediated acute lung injury in mice [J]. Scient Rep, 2015, (5):8347. doi:10.1038/srep08347.
[52] DUNLEVY F K, MARTIN S L, DE COURCEY F, et al. Anti-inflammatory effects of DX-890, a human neutrophil elastase inhibitor [J]. Off J Eur Cystic Fibrosis Soc, 2012, 11(4): 300-304.